Influence of Direct Thrombin Inhibitor and Low Molecular Weight Heparin on Platelet Function in Patients with Coronary Artery Disease: A Prospective Interventional Trial

Direct Thrombin Inhibitor ◽

Thrombin Inhibitor ◽

Low Molecular Weight ◽

Interventional Trial ◽

Angiogenic effects of low molecular weight heparin in patients with stable coronary artery disease: A pilot study

Journal of the American College of Cardiology ◽

10.1016/0735-1097(93)90169-2 ◽

1993 ◽

Vol 22 (3) ◽

pp. 635-641 ◽

Cited By ~ 38

Author(s):

Arshed A. Quyyumi ◽

Jean G. Diodati ◽

Edward Lakatos ◽

Robert O. Bonow ◽

Stephen E. Epstein

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Pilot Study ◽

Stable Coronary Artery Disease ◽

Low Molecular Weight ◽

Randomized trial of low molecular weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study

ACC Current Journal Review ◽

10.1016/s1062-1458(00)00161-6 ◽

2001 ◽

Vol 10 (1) ◽

pp. 15 ◽

Cited By ~ 1

Author(s):

S.G. Goodman ◽

M. Cohen ◽

F. Bigonzi

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Low Molecular Weight ◽

Low-molecular-weight heparin during instability in coronary artery disease

The Lancet ◽

10.1016/s0140-6736(96)90780-1 ◽

1996 ◽

Vol 347 (9010) ◽

pp. 1263

Author(s):

RogerH. Jay

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Long-Term Low-Molecular-Weight Heparin (Fragmin) and/or Early Revascularization During Instability in Coronary Artery Disease (the FRISC II Study)

The American Journal of Cardiology ◽

10.1016/s0002-9149(97)00493-1 ◽

1997 ◽

Vol 80 (5) ◽

pp. 61E-63E ◽

Cited By ~ 22

Author(s):

Lars Wallentin ◽

Steen Husted ◽

Frederic Kontny ◽

Eva Swahn

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Early Revascularization ◽

Low molecular weight heparin (dalteparin) in the management of unstable coronary artery disease (FRIC)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(96)82352-7 ◽

1996 ◽

Vol 27 (2) ◽

pp. 359

Author(s):

W. Klein

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Effects of low-molecular-weight heparin treatment on fibrinolytic markers in unstable coronary artery disease

Fibrinolysis and Proteolysis ◽

10.1054/fipr.2001.0100 ◽

2001 ◽

Vol 15 (1) ◽

pp. 26-31 ◽

Cited By ~ 1

Author(s):

H. Toss ◽

L. Wallentin ◽

A. Siegbahn

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽

Heparin Treatment ◽

Low-Molecular-Weight Heparin and Other Antithrombotic Agents in the Setting of a Primarily Medical Treatment of Unstable Coronary Artery Disease

Pathophysiology of Haemostasis and Thrombosis ◽

10.1159/000054177 ◽

2000 ◽

Vol 30 (2) ◽

pp. 122-127

Author(s):

Freek W.A. Verheugt

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Medical Treatment ◽

Low Molecular Weight ◽

Antithrombotic Agents ◽

Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(00)00808-1 ◽

2000 ◽

Vol 36 (3) ◽

pp. 693-698 ◽

Cited By ~ 100

Author(s):

Shaun G Goodman ◽

Marc Cohen ◽

Frederique Bigonzi ◽

David R Radley ◽

Gregg J Fromell ◽

...

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Low Molecular Weight ◽

Study Group ◽

Reduction of myocardial damage by prolonged treatment with subcutaneous low molecular weight heparin in unstable coronary artery disease

European Heart Journal ◽

10.1053/euhj.1998.1339 ◽

1999 ◽

Vol 20 (9) ◽

pp. 645-652 ◽

Cited By ~ 6

Author(s):

H SATRE

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Myocardial Damage ◽

Prolonged Treatment ◽

Low Molecular Weight ◽

Low-molecular-weight heparin during instability in coronary artery disease

The Lancet ◽

10.1016/s0140-6736(96)90651-0 ◽

1996 ◽

Vol 347 (9009) ◽

pp. 1191 ◽

Cited By ~ 3

Author(s):

D.P. Mikhailidis ◽

I.A. Jagroop ◽

E. Ganotakis ◽

C.J. Knight ◽

A.H. Goodall

Keyword(s):

Coronary Artery Disease ◽

Molecular Weight ◽

Coronary Artery ◽

Low Molecular Weight ◽